Boehringer Ingelheim Ditches Phase II Alzheimer's Program
Another potential treatment for Alzheimer's disease has been tossed into the rubbish bin. Source: BioSpace
Another potential treatment for Alzheimer's disease has been tossed into the rubbish bin. Source: BioSpace
It took more than 8 months and a series of sweetened offers, but Sanofi was able to close their $11.6B deal to buy Bioverativ without triggering an auction. Source: BioSpace
The first of the pink slips at Sandoz' generic-drug manufacturing facility in Broomfield, Colo. have been handed out. Source: BioSpace
MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace
A look at Five Prime, what they do and what they look for in hiring. Source: BioSpace
Rani said the latest funding round brings its coffers a total of $142M. Source: BioSpace
The cash will be used to to execute core strategies of driving commercial adoption of Optune and advancing the clinical pipeline. Source: BioSpace
The cuts were apparently announced in late January with a WARN notice filed with the state. Source: BioSpace
Sanofi is ending a mid-stage program for isatuximab for acute lymphoblastic leukemia, and SAR428926, an anti-LAMP1 ADC for solid tumors. Source: BioSpace
Arbutus said it was undertaking the restructuring in order to better align its hepatitis B business in Warminster, Penn. Source: BioSpace